ProCE Banner Series

Head to Toe Pain Management: Identifying and Managing Patients With Pain to Minimize Adverse Outcomes

Through this Opioid REMS (Risk Evaluation and Mitigation Strategies) Education Initiative, healthcare professionals can earn free REMS-compliant CME/CE credits while gaining a deep understanding of safe opioid practices and current guidelines on pain management and opioid prescription. This initiative equips practitioners with the necessary knowledge and skills on pain management to provide the highest level of care to their patients, ensuring responsible opioid use in healthcare practices.

  AAPA
  | ACPE
  | ADA CERP
  | AMA
  | ANCC with Pharmacotherapy Credit
  | APA
  | ASWB ACE
  | COPE
Who Should Attend

This program is designed to educate HCPs in the United States, particularly HCPs practicing in settings with multidisciplinary and interprofessional healthcare teams, including physicians, advanced practice nurses, physician associates, pharmacists, nurses, psychologists, social workers, dental professionals, and optometrists. Specialty areas include, but are not limited to, physiatry, psychiatry, neurology, family medicine, internal medicine, pain management, and surgery.

All Events

Head to Toe Pain Management: Identifying and Managing Patients With Pain to Minimize Adverse Outcomes

Past Events

November

20

2024

1:00 PM - 3:30 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Chin Hwa (Gina) Dahlem, PhD, FNP-C, FAANP

Clinical Associate Professor 
School of Nursing 
University of Michigan 
Ann Arbor, Michigan 

ProCE Banner Faculty
Andrew Friedman, MD

Section Head, PM&R 
Virginia Mason Medical Center
Medical Director, Psychiatry 
Virginia Mason Franciscan Health
Clinical Assistant Professor 
University of Washington School of Medicine
Seattle, Washington

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Pain Management.

Target Audience
This program is designed to educate HCPs in the United States, particularly HCPs practicing in settings with multidisciplinary and interprofessional healthcare teams, including physicians, advanced practice nurses, physician associates, pharmacists, nurses, psychologists, social workers, dental professionals, and optometrists. Specialty areas include, but are not limited to, physiatry, psychiatry, neurology, family medicine, internal medicine, pain management, and surgery.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify fundamental concepts of pain management, including mechanisms of pain; risk factors for misuse, abuse, and opioid use disorder; and appropriate assessment of pain
  • Create an individualized, patient-specific pain treatment plan that safely and effectively integrates the range of therapeutic options, including initiating therapy, titrating, and discontinuing non-opioid medications and opioid analgesics
  • Design an individualized patient and caregiver education plan on the safe use, storage, and disposal of opioid analgesics and the role of reversal agents
  • Construct a systematic approach to screening for and appropriately managing patients with opioid use disorder

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 2.5 contact hours, including 2.5 hours of pharmacotherapy credit.

Continuing Pharmacy Education

CCO designates this continuing education activity for 2.5 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-24-305-L08-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 2.5 continuing education credits for psychologists.

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 2.5 clinical continuing education credits.

Dental Professionals Continuing Education

Clinical Care Options, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at http://ADA.org/CERP .

Clinical Care Options, LLC designates this activity for 2.5 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at http://ADA.org/CERP

Optometrist Continuing Education

Clinical Care Options, LLC designates this synchronous in-person/virtual activity for a maximum of 2.5 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, and in partnership with Alliance to Advance Comprehensive Integrative Pain Management, American Academy of Physical Medicine and Rehabilitation and Practicing Clinicians Exchange, and ProCE



This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).